Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy

Over the past decade, prostate cancer (PCa) diagnosis drastically evolved from systematic biopsies (SBs) to multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TB), which have emerged as powerful imaging tools for diagnosis, staging, and preoperative planning. MRI and TB should n...

Full description

Bibliographic Details
Main Authors: Cécile Manceau, Jean-Baptiste Beauval, Marine Lesourd, Christophe Almeras, Jean-Romain Gautier, Michel Soulié, Guillaume Loison, Ambroise Salin, Christophe Tollon, Bernard Malavaud, Mathieu Roumiguié, Guillaume Ploussard
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Subjects:
Prostate cancer
Radical prostatectomy
Risk
Biopsy
Targeted biopsies
Magnetic resonance imaging
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320351363

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320351363

Similar Items